The Single Use Bioprocessing Market is experiencing strong expansion as biopharmaceutical manufacturers increasingly adopt flexible, disposable, and pre-sterilized processing systems instead of conventional stainless-steel infrastructure. Single-use technologies are widely used across upstream and downstream manufacturing, helping producers reduce cleaning requirements, shorten facility preparation timelines, and improve operational flexibility.
According to Market Research Future, the Single Use Bioprocessing Market was valued at approximately USD 31.23 billion in 2025 and is projected to increase from USD 35.35 billion in 2026 to USD 107.83 billion by 2035. The market is expected to register a CAGR of 13.2% during the forecast period of 2026–2035. Growing biologics pipelines, increasing CDMO activity, cell and gene therapy manufacturing, and investments in modern biomanufacturing facilities are among the major factors supporting market expansion.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/9131
Market Drivers
Expansion of Biologics Manufacturing
The growing development and commercialization of monoclonal antibodies, vaccines, recombinant proteins, and other biologics is creating sustained demand for adaptable manufacturing infrastructure. Single-use systems allow manufacturers to deploy processing capacity without the extensive cleaning and sterilization infrastructure required by traditional stainless-steel systems.
Biopharmaceutical companies can use disposable bioreactors, bags, tubing, filtration assemblies, and connectors to support multiple manufacturing campaigns. This flexibility is especially valuable when production volumes or product requirements change rapidly. The continued expansion of biologics pipelines therefore remains one of the most important growth factors for the Single Use Bioprocessing Market.
Growth of Contract Development and Manufacturing Organizations
CDMOs are becoming important users of single-use technologies because their facilities frequently manufacture products for multiple clients. Disposable processing equipment can simplify product changeovers and reduce the potential for cross-contamination between campaigns.
According to the MRFR report, the CDMO end-user segment is projected to grow at approximately 16.0% CAGR through 2035, faster than the overall market. The increasing outsourcing of development and manufacturing activities by emerging biotechnology companies is therefore expected to support demand for single-use systems.
Increasing Adoption of Cell and Gene Therapy Manufacturing
Cell and gene therapies require highly controlled manufacturing environments, specialized process workflows, and flexible production capabilities. Many of these products are manufactured at relatively small or medium scales, making single-use equipment an attractive option.
Closed disposable assemblies can support sterile processing while reducing the need for extensive fixed infrastructure. As more cell and gene therapy candidates progress through clinical development and commercialization, manufacturers are expected to increase their adoption of single-use bioreactors, filtration systems, bags, connectors, and other disposable components.
Integration of Automation and Process Analytics
The integration of sensors, process analytical technology, automation, and artificial intelligence is creating another growth avenue. Disposable sensors can monitor parameters such as dissolved oxygen, pH, biomass, and other process variables without requiring extensive fixed equipment.
The sensors and analytics category is identified as one of the fastest-growing product segments, with an estimated 17.5% CAGR through 2035. Greater integration between disposable equipment and digital manufacturing platforms is expected to improve process monitoring and production efficiency.
Market Challenges
Plastic Waste and Sustainability Concerns
A major challenge facing the Single Use Bioprocessing Market is the amount of polymer waste generated after production campaigns. Disposable bags, tubing, filters, connectors, and other components must generally be discarded after use, creating sustainability concerns for manufacturers and regulators.
Growing attention to environmental performance is encouraging suppliers to investigate recycling, polymer recovery, improved material efficiency, and lower-impact manufacturing methods. Sustainability considerations may increasingly influence procurement decisions, particularly across European markets.
Supply Chain Dependence on Specialized Polymers
Single-use bioprocessing equipment depends heavily on specialized medical-grade films, polymers, tubing, and connectors. Supply disruptions affecting these materials can result in longer lead times and increased manufacturing costs.
Manufacturers are consequently examining dual sourcing, regional production, strategic inventories, and supplier diversification to improve supply-chain resilience. Developing reliable sources for critical single-use components will remain important as global adoption increases.
Scale Limitations
Although single-use technology has become widely accepted for clinical and commercial applications, very large manufacturing volumes can present technical and economic limitations. Stainless-steel systems continue to have advantages for certain high-volume production environments.
The MRFR report notes that single-use bioreactor technology is particularly established at scales up to around 2,000 liters, while larger systems remain more limited. Continued innovation in films, bag design, sensors, and large-volume bioreactor architecture will be necessary to expand the technology’s addressable market.
Browse In-depth Market Research Report on Single Use Bioprocessing Market:
Single Use Bioprocessing Market
Market Segmentation
By Product
The Single Use Bioprocessing Market is segmented into filtration assemblies, disposable bioreactors, disposable mixers, media bags and containers, and other products.
Single-use bioreactors represented approximately 42% of market revenue in 2025, making them one of the most important product categories. Their adoption is supported by the replacement of conventional stainless-steel vessels and the expansion of upstream cell-culture capacity.
Filtration assemblies generated approximately USD 5.8 billion in 2025, reflecting the growing importance of downstream purification. Sensors and analytics are projected to be among the fastest-growing categories, supported by increasing process automation and real-time monitoring.
By Workflow
Based on workflow, the market is divided into upstream processing, fermentation, and downstream processing.
Upstream processing accounted for approximately 57% of revenue in 2025. Bioreactors, media bags, and mixing systems are extensively used during cell expansion and production, making upstream operations a major source of demand.
Downstream processing is also expanding as manufacturers increasingly use membrane-based purification, filtration, and single-pass technologies. The downstream segment is projected to grow at approximately 14.6% CAGR through 2035.
By Application
The major applications include filtration, purification, cell culture, and other processing activities.
Cell culture applications benefit significantly from disposable bioreactors and media-handling systems. Filtration and purification applications are also gaining importance as biologics manufacturers seek faster processing cycles and reduced cleaning-validation requirements.
By End User
The market is segmented into biopharmaceutical manufacturers, CDMOs, clinical and academic research institutes, and other end users.
Biopharmaceutical companies accounted for approximately 69.5% of market revenue in 2025. These organizations increasingly use single-use technologies for monoclonal antibody, vaccine, and other biologics manufacturing.
CDMOs represent the fastest-growing end-user category, with a projected CAGR of approximately 16.0% through 2035. Their requirement for rapid product changeovers and flexible multi-client facilities makes disposable processing infrastructure particularly attractive.
By Scale
The market can also be categorized into commercial scale and clinical scale.
Commercial-scale manufacturing generated approximately 72% of revenue in 2025 because approved biologic products require substantial volumes of consumables during production. Clinical-scale operations, however, are expected to experience faster growth at approximately 14.5% CAGR as more biologic candidates move through clinical development.
Regional Insights
North America
North America held the largest regional position in the Single Use Bioprocessing Market, accounting for approximately 38.2% of revenue in 2025. The United States dominates the region because of its strong biotechnology ecosystem, extensive biologics pipeline, established CDMO infrastructure, and high investment in biopharmaceutical manufacturing.
The region is also benefiting from greater adoption of automation, process analytics, cell and gene therapy production, and modular manufacturing facilities. Canada contributes through its growing biotechnology and vaccine manufacturing capabilities, while Mexico is developing opportunities related to nearshoring and pharmaceutical manufacturing.
Europe
Europe represented approximately 28.5% of market revenue in 2025. Germany, the United Kingdom, France, Italy, and other European markets contribute to the regional bioprocessing ecosystem.
Regulatory emphasis on contamination control and sterile manufacturing is encouraging pharmaceutical manufacturers to examine closed and disposable processing technologies. Europe is also becoming increasingly focused on sustainability, encouraging suppliers to develop recycling programs and environmentally improved single-use materials.
Asia-Pacific
Asia-Pacific is expected to be the fastest-growing regional market, with a projected CAGR of approximately 14.2% through 2035.
China, India, Japan, and South Korea are important contributors. Growing biosimilar manufacturing, government support for pharmaceutical production, biotechnology investments, and new CDMO facilities are creating significant opportunities.
India is projected to record particularly strong growth, with an estimated 15.6% CAGR through 2035. South Korea is also benefiting from expansion by major biologics manufacturers and CDMOs.
South America
South America is an emerging market for single-use technologies. Brazil represents the largest opportunity in the region, supported by pharmaceutical manufacturing, vaccine production, research institutions, and biotechnology initiatives.
The regional market is projected to grow at approximately 13.8% CAGR through 2035 as manufacturers modernize production infrastructure and international companies diversify their manufacturing footprints.
Middle East & Africa
The Middle East and Africa represent an earlier-stage but increasingly promising market. Pharmaceutical manufacturing investments in Saudi Arabia, biotechnology development in the UAE, and vaccine manufacturing initiatives in South Africa are supporting regional demand.
Saudi Arabia is projected to achieve approximately 14.1% CAGR through 2035, supported by pharmaceutical manufacturing investments associated with Vision 2030.
Key Players
The competitive landscape includes several established bioprocessing technology and life-science companies, including:
- Sartorius AG
- Cytiva
- Thermo Fisher Scientific
- Merck KGaA / MilliporeSigma
- Pall Corporation
- Repligen Corporation
- Saint-Gobain Life Sciences
- Parker Hannifin
- Avantor
- Entegris
Competition is centered on disposable bioreactor performance, filtration efficiency, polymer and film technology, sensor integration, process automation, supply-chain reliability, and complete end-to-end single-use manufacturing solutions. The top five suppliers collectively account for an estimated 55–62% of market revenue, according to the MRFR report.
Future Outlook
The future of the Single Use Bioprocessing Market is expected to be shaped by the convergence of disposable manufacturing, automation, artificial intelligence, continuous processing, and advanced biologic therapies.
AI-enabled process control could improve manufacturing consistency by allowing real-time analysis of data generated by disposable sensors. Digital twins and connected manufacturing platforms may also enable manufacturers to simulate production campaigns, identify potential process problems, and optimize operating parameters before a batch is completed.
Continuous bioprocessing is another important opportunity. Combining perfusion bioreactors with continuous purification can support longer production campaigns while maintaining controlled sterile pathways. Single-use assemblies are well suited to these workflows because they can reduce cleaning requirements and simplify fluid-path management.
Cell and gene therapy manufacturing is expected to remain a major long-term growth engine. These therapies frequently require flexible, closed, and highly controlled production systems, creating demand for specialized disposable assemblies and scalable processing technologies.
Sustainability will simultaneously become more important. Manufacturers are expected to invest in improved polymer formulations, recycling initiatives, take-back programs, lower-material designs, and life-cycle assessment. Suppliers that can combine manufacturing efficiency with measurable environmental improvements may gain a stronger position as sustainability requirements become increasingly integrated into procurement decisions.
Overall, the Single Use Bioprocessing Market is positioned for substantial expansion through 2035. With the market projected to increase from USD 31.23 billion in 2025 to USD 107.83 billion by 2035 at a 13.2% CAGR, the transition toward flexible, modular, digitally connected, and disposable biomanufacturing infrastructure is expected to remain a defining trend across the global pharmaceutical and biotechnology industries.
Related Report:
- Bioprocessing Market
- Biopharmaceuticals Market
- Cell Culture Market
- Bioreactors Market
- Pharmaceutical Manufacturing Market
- Contract Development and Manufacturing Organization Market
About Market Research Future:
Market Research Future (MRFR) is a global market research and consulting organization providing syndicated research reports, customized research, and industry analysis across multiple sectors. Its reports cover market trends, competitive landscapes, regional developments, growth opportunities, and future forecasts to support strategic business decisions.
Follow Us:
Stay connected with Market Research Future for the latest market intelligence, industry insights, emerging trends, and business research updates.
Contact:
Market Research Future
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com/
